Cori GT, Cori CF. Glucose-6-phosphatase of the liver in glycogen storage disease. J Biol Chem. 1952 Dec. 199(2):661-7. [Medline].
Narisawa K, Igarashi Y, Otomo H, Tada K. A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system. Biochem Biophys Res Commun. 1978 Aug 29. 83(4):1360-4. [Medline].
Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov. 16 (11):e1. [Medline].
Nguyen AD, Pan CJ, Weinstein DA, Chou JY. Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients. Mol Genet Metab. 2006 Nov. 89(3):233-8. [Medline].
Melis D, Cozzolino M, Minopoli G, et al. Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study. J Pediatr. April 2015. 166:1079-1082. [Medline].
Bernier AV, Correia CE, Haller MJ, et al. Vascular dysfunction in glycogen storage disease type I. J Pediatr. 2009 Apr. 154(4):588-91. [Medline].
Cabrera-Abreu J, Crabtree NJ, Elias E, et al. Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX. J Inherit Metab Dis. 2004. 27(1):1-9. [Medline].
Minarich LA, Kirpich A, Fiske LM, Weinstein DA. Bone mineral density in glycogen storage disease type Ia and Ib. Genet Med. 2012 Apr 5. [Medline].
Calderaro J, Labrune P, Morcrette G, et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013 Feb. 58(2):350-7. [Medline].
Correia CE, Bhattacharya K, Lee PJ, et al. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr. 2008 Nov. 88(5):1272-6. [Medline].
Koeberl DD. In search of proof-of-concept: gene therapy for glycogen storage disease type Ia. J Inherit Metab Dis. 2012 Feb 7. [Medline].
Das AM, Lücke T, Meyer U, Hartmann H, Illsinger S. Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth. Ann Nutr Metab. 2010. 56(3):225-32. [Medline].
Melis D, Pivonello R, Cozzolino M, et al. Impaired bone metabolism in glycogen storage disease type I is associated with poor metabolic control in type Ia and with granulocyte-colony stimulating factor therapy in type Ib. Horm Res Paediatr. January 2014. 81:55-62. [Medline].
Ambruso DR, McCabe ER, Anderson D, et al. Infectious and bleeding complications in patients with glycogenosis Ib. Am J Dis Child. 1985 Jul. 139(7):691-7. [Medline].
Baker L, Dahlem S, Goldfarb S, et al. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int. 1989 Jun. 35(6):1345-50. [Medline].
Bashan N, Hagai Y, Potashnik R, Moses SW. Impaired carbohydrate metabolism of polymorphonuclear leukocytes in glycogen storage disease Ib. J Clin Invest. 1988 May. 81(5):1317-22. [Medline].
Bianchi L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr. 1993. 152 Suppl 1:S63-70. [Medline].
Bodamer OA, Feillet F, Lane RE, et al. Utilization of cornstarch in glycogen storage disease type Ia. Eur J Gastroenterol Hepatol. 2002 Nov. 14(11):1251-6. [Medline].
Chen YT, Coleman RA, Scheinman JI, et al. Renal disease in type I glycogen storage disease. N Engl J Med. 1988 Jan 7. 318(1):7-11. [Medline].
Chen YT, Cornblath M, Sidbury JB. Cornstarch therapy in type I glycogen-storage disease. N Engl J Med. 1984 Jan 19. 310(3):171-5. [Medline].
Chen YT, Scheinman JI, Park HK, et al. Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. N Engl J Med. 1990 Aug 30. 323(9):590-3. [Medline].
Chou JY, Mansfield BC. Gene therapy for type I glycogen storage diseases. Curr Gene Ther. 2007 Apr. 7(2):79-88. [Medline].
Greene HL, Slonim AE, O'Neill JA Jr, Burr IM. Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. N Engl J Med. 1976 Feb 19. 294(8):423-5. [Medline].
Heyne K, Henke-Wolter J. Glycogen storage disease Ib: modification of alpha 1-antitrypsin glycoprotein microheterogeneity. Eur J Pediatr. 1989 Jan. 148(4):341-3. [Medline].
Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis. 2007 Apr. 30(2):159-64. [Medline].
Leuzzi R, Banhegyi G, Kardon T, et al. Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b. Blood. 2003 Mar 15. 101(6):2381-7. [Medline].
Martens DH, Rake JP, Schwarz M, Ullrich K, Weinstein DA, Merkel M. Pregnancies in glycogen storage disease type Ia. Am J Obstet Gynecol. 2008 Jun. 198(6):646.e1-7. [Medline].
Martin AP, Bartels M, Schreiber S, Buehrdel P, Hauss J, Fangmann J. Successful staged kidney and liver transplantation for glycogen storage disease type Ib: A case report. Transplant Proc. 2006 Dec. 38(10):3615-9. [Medline].
Melis D, Parenti G, Della Casa R, et al. Brain damage in glycogen storage disease type I. J Pediatr. 2004 May. 144(5):637-42. [Medline].
Melis D, Parenti G, Della Casa R, et al. Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr. 2003 Dec. 92(12):1415-21. [Medline].
Mundy HR, Hindmarsh PC, Matthews DR, et al. The regulation of growth in glycogen storage disease type 1. Clin Endocrinol (Oxf). 2003 Mar. 58(3):332-9. [Medline].
Rake JP, Visser G, Huismans D, et al. Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study. J Inherit Metab Dis. 2003. 26(4):371-84. [Medline].
Roe TF, Coates TD, Thomas DW, et al. Brief report: treatment of chronic inflammatory bowel disease in glycogen storage disease type Ib with colony-stimulating factors. N Engl J Med. 1992 Jun 18. 326(25):1666-9. [Medline].
Roe TF, Thomas DW, Gilsanz V, et al. Inflammatory bowel disease in glycogen storage disease type Ib. J Pediatr. 1986 Jul. 109(1):55-9. [Medline].
Roy CN, Weinstein DA, Andrews NC. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res. 2003 Mar. 53(3):507-12. [Medline]. [Full Text].
Talente GM, Coleman RA, Alter C, et al. Glycogen storage disease in adults. Ann Intern Med. 1994 Feb 1. 120(3):218-26. [Medline]. [Full Text].
Veiga-da-Cunha M, Gerin I, Van Schaftingen E. How many forms of glycogen storage disease type I?. Eur J Pediatr. 2000 May. 159(5):314-8. [Medline].
Visser G, Rake JP, Labrune P, et al. Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1. Eur J Pediatr. 2002 Oct. 161 Suppl 1:S120-3. [Medline].
Visser G, Rake JP, Labrune P, et al. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Eur J Pediatr. 2002 Oct. 161 Suppl 1:S83-7. [Medline].
Wolf B, Freehauf CL, Thomas JA, et al. Markedly elevated serum biotinidase activity may indicate glycogen storage disease type Ia. J Inherit Metab Dis. 2003. 26(8):805-9. [Medline].